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Immunolocalization of V1 vasopressin receptors in the rat kidney using
anti-receptor antibodies. By using immunocytochemical techniques we
have been able to localize the V1 vasopressin receptor in the rat kidney.
Immunoblotting using an antiserum raised against an affinity-purified
vasopressin receptor showed a 55,000 daltons protein band that has a
molecular mass similar to that of the liver V1 vasopressin receptor, as
demonstrated by cross-linking studies. Immunoblotting of the antibody
showed a band of 55,000 daltons in A-10 cells, which contains the V1
subtype, whereas it did not stain LLC-PK1 cells, which possess the V2
subtype, showing that the antibody recognizes the V1 vasopressin receptor.
The immunostaining of kidney sections with this antiserum showed a
strong reaction of the connecting tubules and cortical and medullary
collecting ducts. The immunostaining pattern of connecting tubule and
collecting duct cells was different, that is, the former showed a staining of
both the apical and basal plasma membrane but also in the cytoplasm,
whereas the latter showed a strong reaction mainly in the basolateral
membrane. Immunostaining of consecutive serial sections with an anti-
serum raised against tissue kallikrein, an enzyme present exclusively in
connecting tubules, and with the anti-receptor serum allowed us to show,
for the first time, the presence of the vasopressin receptor in the
connecting tubule cells and their absence in intercalated cells, the other
cell type present in connecting tubules. These findings support experi-
ments carried in the eighties on the release of renal tissue kallikrein by
AVP.
Vasopressin (AVP) is synthesized in the supraoptic nucleus of
the hypothalamus, packaged into secretory granules and released
at the neural lobe into the bloodstream under adequate stimulus
by a calcium dependent mechanism [1].
Vasopressin plays an important role in the fluid and electrolyte
balance by regulating water and solute reabsorption in the kidney.
This role is carried out by the binding of AVP to specific
membrane receptors. The vasopressin receptors have been clas-
sified into two types that are functionally coupled to different
transduction systems: the V1 receptor is coupled to phospholipase
C and therefore produces 1,2,4-inositol triphosphate and diacyl-
glycerol [2]; the V2 receptor is associated with adenylate cyclase,
which in turn increases the intracellular levels of cyclic AMP [3].
The V1 receptor has been further subdivided into the Via for the
vascular and hepatic subtypes and the Vib for the adenohypophy-
sial subtype according to their pharmacological properties [4].
Recently, the eDNA and the predicted sequences for the rat Via
and V2 receptors have been reported [5, 6]. Both cDNAs encode
proteins with seven transmembrane domains as the other G-
protein coupled receptor family.
The V1 receptor has been found in the liver, brain, platelets and
vascular smooth muscle cells [7—10] whereas the V2 receptor has
been detected in the kidney and in the seminal vesicles [ii, 12].
There is also pharmacological, biochemical and autoradiographi-
cal evidence that the V1 receptor is present in the distal nephron
[13—is]. The presence, in the kidney, of the Via receptor messen-
ger RNA has been confirmed by in situ hybridization [16] and by
reverse transcription and PCR in isolated rat nephrons [17, 18].
However, there are still discrepancies about the exact location and
proportion of the Via receptor in the different segments of the
nephron.
Several approaches have been used to localize the vasopressin
receptors in the kidney. Autoradiographic techniques or fluores-
cent microscopy using radio- or fluorescent-labeled vasopressin or
its analogues have been employed to detect AVP binding sites [14,
15, 19, 20], but this technique lacks of enough resolution. Immu-
nochemical methods using anti-vasopressin or anti-idiotypic anti-
bodies to localize the AVP receptors have also been used [21—23],
however, these techniques have not provided precise information
on the specific tubular cell types that express the AVP receptor.
On the other hand, a detailed immunocytochemical description
and localization of the vasopressin V1 and the V2 receptors in the
kidney using anti-receptor antibodies has not been carried out.
We have identified the Via receptor from rat and pig liver as a
monomeric protein of approximately 60,000 daltons [24]. This
receptor was later purified by affinity chromatography and poly-
clonal antibodies were raised against it [25]. We have used these
anti-receptor antibodies in conjunction with autoradiographic
techniques using a specific ligand to localize the Via vasopressin
receptor in the rat kidney.
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METHODS
Production and specificity of antibodies
The anti-receptor antibodies were raised in rabbits against a
fraction eluted from an affinity column. Rat liver membranes were
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then solubilized with 20 mi CHAPS (3-[3-cholamidopropyl)-
dimethylammonioj-1-propanesulfonate) and the extract passed
through a lysine-vasopressin Sepharose column. The column was
successively washed with Tris-HCI buffer, pH 7.4, and eluted with
glycine-HCI, pH 2.5, and 0.5% SDS. Reconstitution of fractions
and assay using a V1 labeled antagonist showed that most of the
receptor binding activity was present in fractions eluting with the
buffer, pH 2.5, and particularly in fractions eluting with 0.5% SDS.
Polyclonal antibodies were raised against fractions eluting with
pH 2.5 buffer and against fractions eluting with SDS. The anti-
bodies were characterized by immunoblotting, immunoprecipita-
tion and immunocytochemistry. In addition, these results were
compared with those obtained by cross linking experiments. This
antibody was used to localize rat liver V1 vasopressin receptor.
Tissue kallikrein antiserum was used as a marker of connecting
tubules, which is a nephron segment that is not clearly distin-
guished on conventionally stained sections. Tissue kallikrein is a
serine-protease that localizes exclusively in this late portion of the
mammalian nephron [261.
Membrane preparation
Rat liver membranes were obtained as it was previously de-
scribed [24] and rat kidney membranes were prepared by density
gradient centrifugation based on the method described by Bock-
aert eta! [111. Briefly, lOg of rat kidney were homogenized in 250
ml 1 m sodium bicarbonate containing a mixture of the following
inhibitors: 0.2 m'vi PMSF, 1 tg/ml leupeptin, 1 g/ml pepstatin, 1
p.g/ml aprotinin and 0.1 jig/mI antipain. The homogenate was
filtered through a gauze and centrifuged at 1200 X g for 10
minutes at 4°C. The pellet was resuspended in 69% wt/wt sucrose
to give a final sucrose concentration of 44% wt/wt. Fourteen
milliliters of the mixture were placed in an ultracentrifuge tube
and 7 ml of 42.3% wt/wt sucrose solution were carefully added on
the top. Centrifugation was carried out at 80,000 x g for one hour
at 4°C. Membranes were collected from the 42.3% sucrose-air
interface, washed with homogenization buffer and centrifuged at
30,000 X g for 30 minutes. Finally, the membranes were resus-
pended, by sonication, in 0.25 M sucrose containing the same
inhibitors included in the homogenization buffer. The membranes
were kept frozen at —20°C until use.
Immunoprecipitation
Rat liver membranes were solubi!ized with 10 mvi CHAPS for
30 minutes at 4CC, then diluted to a final concentration of Cl-TAPS
of 2 m and 50 jil of anti-vasopressin serum were added. After
overnight incubation at 4°C 60 jd of a protein A-agarose suspen-
sion were added and incubated for an additional two hours. The
protein A-agarose was collected by centrifugation and resus-
pended in sample buffer. The protein was separated by electro-
phoresis and radioactivity detected by autoradiography.
Immunoblotting
Membrane proteins were separated by polyacrylamide gel
electrophoresis and electrotransferred onto nitrocellulose sheets
that were incubated with the anti-vasopressin receptor serum
diluted 1:200. The nitrocellulose membranes were then washed
and incubated with a peroxidase-labeled second antibody (Bio-
Rad) diluted 1:3000. The peroxidase was developed using 4-
Chloro-1-Naphthol and H202.
Immunocytochemistry
Rat kidney slices 1 to 2 millimeters thick were fixed by
immersion in Bouin's fluid dehydrated in ethanol and embedded
in paraplast plus or methacrylate [27]. The latter embedding
medium allowed us to perform the immunostaining for the AVP
receptor and for tissue kallikrein in two consecutive 1 jim thick
sections. This meant that the same cells were immunostained with
two different antibodies. Both embedding media were removed
before immunostaining by immersion in xylene (2 X 15 mm).
Paraplast sections (5 to 7 jim thick) or methacrylate (1 jim) were
then sequentially incubated with various dilutions of the anti-
receptor serum (1:800) for 18 hours at room temperature, with a
secondary antibody sheep anti-rabbit IgG. (1:50) for 30 minutes,
washed with buffer and incubated with the PAP complex (1:100)
for 30 minutes. The peroxidase was detected with 3,3-diamino-
benzidine and H202. Between incubations, the sections were
rigorously washed with buffer (3 x 5 mm). A titration study of the
antibody was carried out with different dilutions of the antiserum
in order to use the highest possible dilution to avoid the nonspe-
cific reaction of the antibody. Control studies included omission
or replacement of the primary antiserum by a pre-immune serum.
In addition, some sections were stained with the vasopressin
receptor anti-serum that was previously absorbed with purified rat
liver membranes, which are known to have only V1 receptor.
lodination procedure
Lysine vasopressin (LVP) or the specific V1 antagonist Phaa,D-
Tyr(Me)2,Arg6,Tyr9(NH2)AVP (kindly provided by Prof. M Man-
ning) were radiolabeled with 125J using lodogen as previously
described [28] or by the chloramine T method. The monoradio-
iodinated peptide was separated from the free iodine, the non-
labeled and the diradioiodinated peptides by HPLC on a C18
column with a linear gradient of acetonitrile.
Autoradiography
Rats were killed by decapitation and the kidneys immediately
frozen in liquid nitrogen and then sections (16 jim thick) were
obtained using a cryostat at —20°C. Sections were freeze-dried,
hydrated with 50 m phosphate buffer, pH 7.4, and incubated with
50 or 100 M of the iodinated V1 antagonist Phaa,D-Tyr(Me)2,
Arg6,Tyr(NH2)°AVP for 24 hours at 4°C. After incubation was
completed the sections were washed with cold phosphate buffer
and cold distilled water. In some experiments the labeled antag-
onist was incubated in the presence of non-labeled antagonist,
AVP or desmopressin (dDAVP; a V2 specific agonist). The
sections were dried for two hours at 37°C and exposed to Kodax
XAR-5 film.
RESULTS
Antiserum characterization
To determine the specificity of the antibody, Western blots
were carried out using purified plasma membranes from liver and
kidney and cell lines expressing either V1 or V2 receptors or cells,
which have no detectable vasopressin binding sites. Nitrocellulose
immunoblots containing membrane proteins separated by electro-
phoresis showed one main band of Mr 55,000 for kidney mem-
branes and two faint bands running slightly faster and slower than
the main band (Fig. IC). Replacement or omission of the primary
antiserum showed no immunoreaction with membrane proteins
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Fig. 2. Characterization of the antibody against the vasopressin recep-
tor. Western blot analyses of rat liver membranes (A) COS 7 cell, A-b cell
and LLC-PK1 cell membranes (B). A band of approximately 55,000
daltons can be observed in rat liver membranes and in A-10 cells both of
which contain Via receptor whereas no detectable band can be observed
in neither COS 7 nor LLC-PK1 cells, the former has no vasopressin
binding sites and the latter endow V2 vasopressin receptors.
A B C
Fig. 1. Molecular characterization of the V vasopressin receptor. Cross-
linking experiments (A) of rat liver membranes which were incubated with
'251-LVP and EGS lane 1 and in lane 2 an excess (1 j.M) of non-labeled
LVP was added to the reaction mixture. The complete displacement of the
radioactive LVP from the 60,000 daltons band can be observed. Autora-
diograph of a polyacrylamide SDS gel containing an immunoprecipitate
using vasopressin receptor antiserum of 1251-labeled vasopressin receptor
after solubilization with CHAPS (B). Western blot analysis of rat kidney
membranes using an antiserum raised against the rat vasopressin receptor
(C). A main band of approximately 55,000 daltons and minor ones of
45,000 and 70,000 daltons can be seen.
(data not shown). Immunoblots of rat liver membranes (Fig. 2A)
showed one band with a similar molecular weight to that of kidney
membranes (Fig. IC). The immunostaining of nitrocellulose
containing membrane protein from COS 7 cells (Fig. 2B, lane 1),
which lack detectable vasopressin binding sites [5], A-b cells (Fig.
2B, lane 2), which express the Via receptor [29], a cell line derived
from rat aorta smooth muscle and LLC-PK1 cells (Fig. 2B, lane 3),
which contain the V2 receptor [30], showed that only the A-b
cells are reactive with the antibody as expected. The molecular
weight of the immunoreactive band shown by the A-b cells was
similar to that shown by rat liver membranes (Fig. 2A). The
molecular mass for the vasopressin receptor shown by the im-
mublot technique was similar to that obtained by autoradiography
of SDS gels containing rat liver membranes that were incubated
with '251-labeled lysine-vasopressin and then cross-linked with
EGS [ethylene glycol bis(succinimidyl succinate); Fig. 1A]. More-
over, the antiserum raised against the affinity purified receptor
was able to immunoprecipitate the '251-LVP labeled receptor
from CHAPS solubilized membranes that had been cross-linked
with 1251-LVP and EGS (Fig. 1B).
Autoradiography
The iodinated V1 specific linear antagonist was used to deter-
mine the V1 binding sites in the rat kidney. A heavy labeling was
observed on the cortex with a radial pattern and in the inner stripe
of the outer medulla and in the inner medulla. The pelvic wall was
also labeled, as well as the wall of arteries and arterioles (Fig. 3).
This labeling was readily displaced by the addition of an excess of
AVP (Fig. 3 E, F) or of non-radioactive antagonist (Fig. 3 B, C).
However, dDAVP, a potent V2 agonist, was unable to displace the
iodinated V1 antagonist (Fig. 3 H, I).
Immunocytochemistry
Omission of the primary antiserum (not shown) or incubation
with an antiserum that had been absorbed with rat liver mem-
branes (Fig. 4C) showed no staining at all. Immunostaining of
kidney sections with the vasopressin receptor antiserum showed
the staining of tubules in the cortex, and a strong staining of the
tubules in the inner stripe of the outer medulla and to a lesser
extent the outer part of the inner medulla (Fig. 4 A, B). In the
cortex, apparently two types of tubules were immunostained with
a different pattern. The first seemed to be connecting tubules with
narrow lumen and consisted of large cube-shaped cells that gave
a strong staining throughout the cytoplasm (Fig. 4A). The second
type had the typical morphology of collecting ducts and had a
wider lumen (Fig. 4 A, B). The principal cells of the cortical and
1208 Gonzalez et al: Vasopressin receptors in the rat kidney
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Fig. 3. Autoradiograms of coronal rat kidney sections using the V1 antagonist labeled with 125! (4,D, G). Autoradiograms of displacement experiments
using: a 50 flM concentration of AVP (B), V1 antagonist (E) and dDAVP (H) and 500 n concentration of AVP (C), Vi antagonist (F), and dDAVP
(I). Magnifications approximately X5 to X6.
m
 
-
ii 
C'
) 
a
 
St
 
w
 
1'
 
"
I 
T 
S 
Gonzalez ci al: Vasopressin receptors in the rat kidney 1209
It.
 
-
-
V 
-
 
.
 
7O
9t
 0
c•
- - 
'r-
 
.
•
/ 1
i'g
ç.
 
a
- 
—
-
-
-
 
-
 
I. 
fr-
'. -
a
A 
C)
 D
 
00
 
I 
:i1
::.
 A 
C S-
I 
-
Th
L 
2 
'-
4-
 
-
I.-
--,
 iw
.-.
_ 
-
't 
1210 Gonzalez et a!: Vasopressin receptors in the rat kidney
Fig. 4. Immunocytochemical staining of rat kidney sections with anti-vasopressin receptor (A and B) and with a vasopressin antiserum absorbed with
purified liver membranes enriched in V1 receptor (C). In A micrograph of the cortex (C) and the outer stripe (OS) of the outer medulla (OM)
(magnification X50). The staining of connecting tubules (CT) and collecting ducts (CD) in the cortex (C) and also the staining of collecting ducts in
the outer medulla is seen. Because of the delicate staining of the basolateral membrane, this can only be seen at higher magnification (inset). In B a
micrograph of the inner stripe (IS) of the outer medulla (OM) and the inner medulla is shown. The staining of the thick ascending loop of Henle (TAL)
and the collecting ducts (CD) can be observed. In C, a section is similar to A but immunostained with the vasopressin receptor antiserum that has been
absorbed with liver membranes enriched in V receptor.
the outer medullary collecting ducts showed a very striking
staining pattern, that is, a very strong reaction was localized in the
basal portion of the cells and a faint staining in the adjacent
cytoplasm (Fig. 5). In the inner medulla, only the collecting ducts
were stained in addition to vasa recta, but a drastic change in the
staining was observed, that is, the cells of the collecting ducts with
the strong basal immunoreaction rapidly disappeared as the
collecting duct went into the inner medulla. Because the shape
and localization of some of the immunoreactive tubules of the
cortex were similar to that of connecting tubules, we used
antibodies raised against tissue kallikrein as a marker for this
nephron segment. In the kidney, this enzyme has been shown to
be exclusively present in connecting tubules [26]. The immuno-
staining of consecutive serial sections (1 jim) with antibodies to
tissue kallikrein and to the vasopressin receptor showed that these
tubules were, in fact, connecting tubules (Fig. 6). Moreover, the
antibody against vasopressin receptor stained the same cells as did
the tissue kallikrein antibody, that is, the connecting tubule cells
but not the intercalated cells (Fig. 6 B, D).
Immunostaining of human kidney sections using the antiserum
against rat VI vasopressin receptor showed a similar staining
pattern to that of the rat kidney, that is, the staining of connecting
tubules and the collecting ducts (Fig. 7 A, B). Immunoreactive
tubular cells of the human kidney showed a homogenous staining
throughout the cytoplasm and only some of them showed a strong
staining in the apical or basal membranes (Fig. 7).
DISCUSSION
The eDNA for the Via and the V2 receptor have been recently
shown to encode proteins of a Mr of 44,200 plus two potential
sites for N-glycosylation for the V1, and a Mr of 40,500 plus one
potential site for N-glycosylation for the V2 [5, 6]. In addition,
both proteins contain several potential sites for phosphorylation
that could also produce some heterogeneity on these proteins.
The molecular mass of the band shown by the antiserum is in good
agreement with the molecular mass of the Via receptor deter-
mined by chemical cross-linking [241, the molecular mass of the
receptor from the rat liver, and also with the molecular mass of
the protein deduced from the cDNA sequence of the V1 receptor.
The difference in the molecular weight given by the immunoblot
and cross-linking experiments is due to the fact that in the latter
technique the receptor is covalently bound to the hormone, and
thus runs as a higher molecular weight protein.
The immunostaining of the band on the nitrocellulose contain-
ing membrane proteins from A-b cells and the lack of reaction on
those containing membrane proteins from COS 7 and LLC-PK1,
which expresses the V2 receptor, and the immunoprecipitation of
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Fig. 5. Immunocytochemical staining of a kidney section with the anti-receptor antiserum. A strong immunoreaction of the principal cells of the outer
medullary collecting ducts (CD) can be observed. Note that the reaction is located in the basal side of the cells. An immunoreaction of thick ascending
limb (TAL) cells can be also observed specially in the basal infolding (arrows). Magnifications x700, inset X 1,400.
the 1251-LVP labeled receptor strongly support the idea that the
antibody is recognizing the Via receptor subtype, and it is not
reacting with the V2 subtype. This contention is supported by the
fact that the antiserum precleared against liver enriched in V1
receptor did not show staining of kidney sections.
The presence of immunoreactive V1 receptors and the binding
of '251-antagonist to distal nephron segments prompted the
question as to whether the V1 receptor was present on distal
convoluted or connecting tubules. The use of antibodies directed
to rat urinary kallikrein, an enzyme exclusively present in con-
necting tubules, showed the labeling of the same structure by
antibodies against kallikrein and against the vasopressin receptor.
Therefore, these results clearly indicate that one of the cortical
tubules stained by the anti-vasopressin receptor antiserum corre-
sponds to connecting tubules.
The labeling pattern given by autoradiography, using the V1
antagonist, was similar to the immunostaining pattern given by
immunocytochemistry except in the inner medulla where the
antibody showed a label that decreases towards the papilla,
whereas the autoradiography with the antagonist showed a strong
binding of the inner medulla. This discrepancy might be due to the
reaction of the antagonist with other types of receptors, for
example, the Vib or the oxytocin receptors, which have been
shown to be present in the kidney [20, 311. In fact, this antagonist
is able to bind to rat uterus membrane with a relatively high
affinity [32]. The pattern of immunostaining of the antibody is very
similar to the distribution of the V1 binding sites determined by
autoradiography using a tritiated non-peptide antagonist, the SR
49059 [33].
According to their shape and trajectory some of the tubules of
the cortex labeled by the antagonist seem to be connecting tubules
and the other collecting ducts. The binding of the iodinated-
antagonist was displaced by AVP and the non-labeled Via antag-
onist but not by dDAVP, which is a specific V2 agonist devoid of
vasopressor or anti-vasopressor activities. These results suggest
that the receptor shown by autoradiographic studies is a V1
subtype. We have previously shown that this anti-vasopressin
receptor antiserum stains the liver vasopressin receptor and
reveals a particular distribution of this protein in the hepatic
acinus [341.
The presence of V1 receptor in the kidney has been demon-
strated by autoradiographic and pharmacological studies using
selective ligands. V1 binding sites detected by autoradiography
have been located in collecting ducts of the outer medulla and
also in the cortical collecting ducts [15, 33]. In addition, labeling of
vascular elements such as vasa recta, arcuate, interlobular and the
renal arteries, have also been shown. V1 binding sites in the
cortical collecting ducts have also been detected on microdis-
sected kidney tubules by pharmacological studies using specific
ligands [13]. In the present study, we showed the immunolabeling
mainly of the cortical and outer medullary collecting ducts, but
also, to a minor extent, of the inner medullary collecting ducts.
Our results are in good agreement with previous autoradiographic
studies [15, 331 with respect to the localization and the proportion
-'at C
-
-.
... A. ti. . II. a t..s.. -. •.?jjp- - —
.—- '[
• —L.' C•a \
'1%
• b
PT "tCv
1212 Gonzalez et al: Vasopressin receptors in the rat kidney
Fig. 6. Immunostaining of paraffin (A and C) and methacrylate (B and D) serial sections with antiserum against tissue kallikrein (A and B) and with
anti.vasopressin receptor antiserum (C and D). The connecting tubules numbered from I to 7 stained by the anti-kallikrein antiserum of picture A are
also stained by the anti-vasopressin receptor antiserum (C). Magnification of A and C X500. In B, a thin serial methacrylate section stained with the
anti-kallikrein antiserum showing the localization of the enzyme in the connecting tubule cells (CNTc), whereas the intercalated cells (Ic) appear
unstained. The consecutive serial thin section which was stained with the anti-vasopressin receptor antiserum (D) shows the reaction on the same
connecting tubule cells. Immunoreaction in the proximal tubule (PT) can be also seen in picture B probably representing a reabsorption process of
filtered kallikrein. Note that the same proximal tubule appears negative when the anti-receptor antiserum was used. Magnification of B and D ,350.
of the label in the different regions. These result are also in good
agreement with those given by reverse transcription polymerasc
chain reaction (RT-PCR) where V1 transcripts were found in the
cortical and outer medullary collecting ducts [17, 181.
We showed the presence of the V1 vasopressin receptor in the
connecting cells and its absence in the intercalated cells of the
connecting tubules. In the cortical and outer medullary collecting
ducts some cells were stained by the antibody whereas other cells
appeared to he negative. It is likely, as it happens in the
connecting tubules, that the vasopressin receptors in the collecting
ducts are located in the principal cells. This assumption is in good
agreement with the fact that a fluorescent analogue of AVP binds
to the principal cells in the collecting ducts [191.
The staining of cells of cortical tubules of human kidney is not
surprising since the rat and the human Via receptors have a high
homology (77%), whereas rat Via has a low homology (40%) with
the rat or human V2 receptor.
The staining pattern of collecting duct and connecting tubule
cells was different. While cells from the former showed the
staining in the apical and mainly in the basolateral membranes,
the latter showed the staining in relation to the apical and
basolateral membranes as well as throughout the cytoplasm. This
staining pattern of connecting tubules might reflect a receptor-
mediated endocytosis process, a mechanism that has been associ-
ated with the internalization of the ligand-receptor complex by
coated pits and the dissociation of the complex in early endo-
somes [35]. In fact, it has been shown that both subtypes of
vasopressin receptors can be internalized by endocytosis of the
hormone-receptor complex and receptors recycled to the cell
surface [36—381.
In the present work we found that the thick ascending limb was
stained by the antibody, suggesting the presence of V receptor
subtype in this part of the nephron. The presence of V1, receptor
subtype in this segment is still a controversial issue. Firsov and
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Fig. 7. Immunostaining of human kidney sections with the vasopressin
receptor antiserum. Micrograph showing the immunostaining of tubules
in the cortex of the human kidney (A) a higher magnification of positive
tubular cells (B).
coworkers [17] have found no detectable Via transcript in this
segment by RT-PCR, whereas Terada and colleagues [18] found
small amount of Via mRNA in this segment by the same
technique. Further work will be necessary to substantiate this
issue.
It is generally accepted that, in the kidney, vasopressin produces
water and Na reabsorption and K secretion. Most evidence
indicates that the V2 receptor mediates changes in the urea and
water permeability, thus regulating the water reabsorption. How-
ever, the role of the V1 receptor in the kidney remains unknown.
The high expression of the V1 mRNA during the ontogeny of the
kidney and the well-known mitogenic capacity of vasopressin
through the V1 receptor led Ostrosky and co-workers [161 to
propose a role for the V1 receptor during kidney development.
However, the presence of the V1 receptor in the adult kidney
indicates that this might not be the only function of the V1
receptor in that organ.
Previous studies have described an association between AVP
and renal tissue kallikrein. In fact, experiments in which AVP was
infused into dogs and rats showed a dose-dependent increase in
the urinary excretion of renal tissue kallikrein [39]. Tn addition,
experiments performed using isolated renal cortical slices have
shown that AVP stimulates the release of renal tissue kallikrein
[40]. It is interesting that no such effect was observed when the
cortical slices were prepared from kidneys of spontaneously
hypertensive animals, suggesting a secondary defect to the devel-
opment of hypertension [41]. The presence of V1 receptors in
connecting tubule cells, the site where tissue kallikrein is pro-
duced, supports the action of AVP on the release of this enzyme
from connecting tubule cells, and it suggests that AVP actions in
the kidney may be closely associated to those driven by the
kallikrein-kinin system. Kinins, the peptides released from kini-
nogens by tissue kallikrein [42], have been shown to inhibit the
hydrosmotic effect of antidiuretic hormone in perfused cortical
collecting tubules, but only when the kinin was added to the
basolateral side [43]. Like AVP V1 receptor, kinin B2 receptors
are also extremely abundant in the basal portion of collecting duct
cells [44]. Interaction between both peptides and their corre-
sponding receptors at this level may result in a balanced excretion!
reabsorption of water and electrolytes by the kidney.
It has been shown that vasopressin increases the osmotic water
flow, an action mediated by V2 receptor subtypes, in the cortical
and medullary collecting ducts [45, 46]. These observations are in
agreement with the fact that vasopressin-sensitive water channels
are located in the cortical and medullary collecting ducts, espe-
cially in the inner portion [47]. In the present study, we found that
the V1 receptor subtype is located in the cortical and outer
medullary collecting ducts and to a minor extent in the inner
medullary collecting tubules. It is probably that both subtypes of
receptors coexist in the same cell. In this context, it is interesting
that a modulation of the vasopressin-stimulated water reabsorp-
tion has been proposed that is elicited through a V2 type receptor,
by vasopressin itself through a V1 subtype receptor by the
production of PGE2 [48].
Although a strong staining of the basolateral membrane of
cortical and outer medullary collecting tubules was observed, a
weak staining of the apical membranes was also seen in both
segments. However, this apical staining was more evident in the
connecting tubules and in the inner medullary collecting ducts. A
similar staining pattern, that is, the apical and basolateral mem-
branes, has been found in collecting ducts using vasopressin
anti-idiotypic monoclonal antibodies [23]. These observations are
in agreement with the fact that some of the effects of AVP can be
elicited only from the basolateral side, whereas others only can be
elicited when AVP is applied on the luminal side [49—51].
Moreover, AVP is able to increase cytosolic Ca2, an effect
mediated by the V1 receptor, when it is applied at both the
luminal and the basolateral sides of rabbit cortical collecting ducts
[52]. In this context, it is interesting to note that the concentration
of AVP in the urine is higher than that found in plasma [53].
By using immunocytochemistry with anti-receptor antibodies
and autoradiography with selective a V antagonist we have been
able to show the location of the V1 subtype receptor in different
nephron segments of the rat kidney. By using immunocytochem-
istry of serial sections immunostained for the vasopressin receptor
and for tissue kallikrein, we have been able to show, for the first
time, the presence of V vasopressin receptors in connecting
tubule cells (tissue kallikrcin-producing cells). These results will
allow further studies on the role of the V1 receptor in renal
function.
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